Literature DB >> 34817806

Comprehensive Study of Human FBXW7 Deleterious nsSNP's Functional Inference and Susceptibility to Gynaecological Cancer.

K Archana Vasuki1, H Jemmy Christy2.   

Abstract

Cancer is one of the world's major causes of mortality, and it plays a most important role in the world's declining life expectancy. F-box and WD-40 domain protein 7 (FBXW7), a typical participant of the F-box family of proteins, has been considered as an anti-tumor protein and one of the maximum deregulated ubiquitin-proteasome system proteins in uterine carcinosarcoma, endometrial clear cell carcinoma and cervical carcinoma with the greatest prevalence of alterations. FBXW7 variants with known clinical significance, as well as non-synonymous single nucleotide polymorphisms (nsSNPs) in the F-Box and WD40 domains, were evaluated using functionality prediction web resources. Upon analysing the seventy-three deleterious nsSNP's impact on protein stability and function, we identified that forty-one nsSNPs of WD40 domain and three of F-Box domain imply decreased stability of the FBXW7 structure. Next to TP53 and PTEN, FBXW7 was reported with the highest percentage of arginine substitution among mutations related to cancer. The current research concentrated on two arginine residue locations (Arg465, Arg505) within the WD40-repeat domain, which is vital for substrate binding. Computational analysis revealed significant deviation in stability and structural configuration of mutants R505L, R465H, R465P, R505G, R505C, R465C, R505S and R505L structures. Protein-protein interaction network of FBXW7 populated with promising hub proteins NOTCH1, c-Myc, CCNE1, STYX, KLG5, SREB1, NFKB2, SKP1 and CUL1; thus, alteration in the FBXW7 leads to aberration in their signalling pathways as well as their substrate binding ability makes this protein as attractive target for personalized therapeutic intervention.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cancer; Chemoresistance; FBXW7; Uterine carcinosarcoma; Variants

Mesh:

Substances:

Year:  2021        PMID: 34817806     DOI: 10.1007/s12010-021-03759-7

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  58 in total

Review 1.  F-box proteins: Keeping the epithelial-to-mesenchymal transition (EMT) in check.

Authors:  Víctor M Díaz; Antonio García de Herreros
Journal:  Semin Cancer Biol       Date:  2015-11-11       Impact factor: 15.707

Review 2.  On the origin of cancer metastasis.

Authors:  Thomas N Seyfried; Leanne C Huysentruyt
Journal:  Crit Rev Oncog       Date:  2013

Review 3.  Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities.

Authors:  Ryan J Davis; Markus Welcker; Bruce E Clurman
Journal:  Cancer Cell       Date:  2014-10-13       Impact factor: 31.743

4.  miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7.

Authors:  Chuanyi Zhou; Liangfang Shen; Lei Mao; Bing Wang; Yang Li; Huizhi Yu
Journal:  Biochem Biophys Res Commun       Date:  2015-01-24       Impact factor: 3.575

5.  [Effects of UO-126 on proliferation and fbw7 expression of HeLa cells].

Authors:  Di Sun; Yi Shen; Shao-hua Wang; Zi-wu Xiang; Ying-shan Xie; Xin Jiang
Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi       Date:  2010-02

6.  Small RING Finger Proteins RBX1 and RBX2 of SCF E3 Ubiquitin Ligases: The Role in Cancer and as Cancer Targets.

Authors:  Dongping Wei; Yi Sun
Journal:  Genes Cancer       Date:  2010-07

Review 7.  Function and mechanism of F-box proteins in gastric cancer (Review).

Authors:  Jian Gong; Juan Cao; Guinan Liu; Ji-Rong Huo
Journal:  Int J Oncol       Date:  2015-05-04       Impact factor: 5.650

Review 8.  Recent insight into the role of FBXW7 as a tumor suppressor.

Authors:  Kanae Yumimoto; Keiichi I Nakayama
Journal:  Semin Cancer Biol       Date:  2020-02-27       Impact factor: 15.707

9.  hCDC4 gene mutations in endometrial cancer.

Authors:  Charles H Spruck; Heimo Strohmaier; Olle Sangfelt; Hannes M Müller; Michael Hubalek; Elisabeth Müller-Holzner; Christian Marth; Martin Widschwendter; Steven I Reed
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

10.  The E3 ubiquitin ligase Trim7 mediates c-Jun/AP-1 activation by Ras signalling.

Authors:  Atanu Chakraborty; Markus E Diefenbacher; Anastasia Mylona; Olivier Kassel; Axel Behrens
Journal:  Nat Commun       Date:  2015-04-08       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.